课题基金 / 基金详情

Development of Immunogene therapy using IL-6 for Pancreatic Cancer

Development of Immunogene therapy using IL-6 for Pancreatic Cancer
使用 IL-6 治疗胰腺癌的免疫基因疗法的开发
批准号:
10557106
负责人:
SUGIURA Hiroshi
金额:
$7.81万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SUGIURA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
人胰腺癌细胞产生的白细胞介素-6(IL-6)与裸鼠体内血液向肝脏转移的可能性呈负相关。将IL-6 cDNA转染到PCI-43中,PCI-43是我们培养的胰腺癌细胞系之一,其不产生IL-6并产生许多向肝脏的转移。IL-6高生产克隆(PCI-43 h)产生很少的转移; IL-6生产因此对转移具有直接影响,而分别为IL-6低生产者和IL-6非生产者的其它转染子(PCI-43 l和PCI-43 n)确实产生转移。在体外介导抗体依赖性细胞毒性(ADCC)的肿瘤反应性IgG在接种PCI-43 h的受体裸鼠的血清中检测到,但在给予PCI-43 l、PCI-43 n或亲本PCI-43的小鼠的血清中未检测到。此外,我们使用腺病毒载体测试了N116 Y在阻断胰腺癌细胞体内生长中的功效。将其中N116 Y表达由CEA启动子驱动的AdCEA-N116 Y直接注射到裸鼠的脾脏中显著抑制其肝转移瘤的生长。
英文摘要
Production of interleukin-6 (IL-6) by human pancreatic carcinoma cells inversely correlates with potentials for blood-borne metastasis to the liver in nude mice. IL-6 cDNA was transfected to PCI-43, one of our cultured pancreatic carcinoma cell lines that does not produce IL-6 and generates numerous metastases to the liver. An IL-6 high-producer clone (PCI-43h) generated few metastases; IL-6 production thus has a direct effect on metastasis, whereas other transfectants (PCI-43l and PCI-43n), which are IL-6 low-, and IL-6 non-producers, respectively, did generate metastases. Tumor-reactive IgG, which mediated antibody-dependent cellular cytotoxicity (ADCC) in vitro, was detected in sera from recipient nude mice inoculated with PCI-43h but not in sera from mice given PCI-43l, PCI-43n or parent PCI-43. In addition, we tested the efficacy of N116Y in blocking the in vivo growth of pancreatic cancer cells using an adenoviral vector. Direct injection of the AdCEA-N116Y in which N116Y expression is driven by the CEA promoter, into the spleen in nude mice suppressed their growth of liver metastases significantly.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Toshiya Nishibe: "Expanded Polytetrafluoroethylene Grafts for Portal Vein Replacement : Use of Omentum Wrap to Promote Graft Healing"Surgery Today Jpn J Surg. 27. 149-153 (1998)
Toshiya Nishibe:“用于门静脉置换的膨胀聚四氟乙烯移植物:使用大网膜包裹促进移植物愈合”Surgery Today Jpn J Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeuchi M: "The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice."Gene Ther. (in press).
Takeuchi M:“显性失活 H-ras 突变体 N116Y 可抑制裸鼠肝脏中转移性人类胰腺癌细胞的生长。”Gene Ther。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    The role of cathepsin E in mammary carcinogenesis and prognosis in breast cancer
    • 批准号:
      22591438
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2010
    • 负责人:
      SUGIURA Hiroshi
    • 依托单位:
    Research on High Dimension Problems in Numerical Analysis.
    • 批准号:
      07805009
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1995
    • 负责人:
      SUGIURA Hiroshi
    • 依托单位:
    A Synthetic Research on the Conceptual Change of History and Mythology in the German Thought and Literature since 1970
    • 批准号:
      01450069
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.2万
    • 财政年份:
      1989
    • 负责人:
      SUGIURA Hiroshi
    • 依托单位:
    国内基金
    海外基金
    早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
    七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
    • 批准号:
      JCZRLH202601296
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
    • 批准号:
      JCZRLH202600985
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
    • 批准号:
      JCZRLH202601410
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: